Ranch Capital Advisors Inc. Has $533,000 Holdings in CME Group Inc. $CME

Ranch Capital Advisors Inc. boosted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 5.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,934 shares of the financial services provider’s stock after buying an additional 104 shares during the period. Ranch Capital Advisors Inc.’s holdings in CME Group were worth $533,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Peterson Wealth Services grew its stake in CME Group by 1.8% during the 2nd quarter. Peterson Wealth Services now owns 9,846 shares of the financial services provider’s stock valued at $2,714,000 after acquiring an additional 176 shares in the last quarter. Sage Mountain Advisors LLC grew its stake in CME Group by 7.4% during the 2nd quarter. Sage Mountain Advisors LLC now owns 1,326 shares of the financial services provider’s stock valued at $366,000 after acquiring an additional 91 shares in the last quarter. AlphaQuest LLC grew its stake in CME Group by 230.7% during the 2nd quarter. AlphaQuest LLC now owns 3,611 shares of the financial services provider’s stock valued at $995,000 after acquiring an additional 2,519 shares in the last quarter. West Michigan Advisors LLC grew its stake in CME Group by 2.4% during the 2nd quarter. West Michigan Advisors LLC now owns 8,875 shares of the financial services provider’s stock valued at $2,446,000 after acquiring an additional 207 shares in the last quarter. Finally, Asset Management One Co. Ltd. grew its stake in CME Group by 2.6% during the 2nd quarter. Asset Management One Co. Ltd. now owns 218,570 shares of the financial services provider’s stock valued at $60,242,000 after acquiring an additional 5,557 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $269.54 on Friday. The business’s fifty day moving average price is $266.47 and its two-hundred day moving average price is $271.67. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The stock has a market capitalization of $97.14 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 6.18 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business’s revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business posted $2.68 earnings per share. As a group, analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Insider Transactions at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William R. Shepard purchased 262 shares of the firm’s stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 in the last ninety days. 0.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CME has been the subject of a number of recent analyst reports. The Goldman Sachs Group upped their target price on CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a research report on Thursday. Raymond James Financial decreased their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Piper Sandler upped their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. UBS Group decreased their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Keefe, Bruyette & Woods upped their price target on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $284.53.

Read Our Latest Analysis on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.